Brits buy Dorland Global in $20M deal

Share this article:
Publicly held Huntsworth PLC, based in London, has purchased Dorland Global Corp., for $20.7 million in cash, extending the reach of its healthcare division into the US market.

The acquisition covers its two units, Dorland Global Health Communications and Dorland Global Public Relations.

The sale price for the previously independent agency will be shared by 10 shareholders, along with co-founders Harry and Rita Sweeney. The deal also may include deferred compensation based on Dorland profits for the year ending Dec. 31, 2007, plus a payment to be made based on three-year profits through 2010, Huntsworth said.

The maximum price was capped at $50 million. Dorland reported 2006 gross profit of $3.5 million and gross assets of $11 million as of year end.
The existing management team will continue to operate the business, reporting to David Rowley, chief executive of Huntsworth Health.

Dorland will serve as a US footprint for the Huntsworth Health division, the largest healthcare firm in the UK.

In an interview with MM&M, Rita Sweeney said being part of a larger agency will help Dorland “take on and pitch and win larger global accounts…that was the whole strategy to begin with.”

Share this article:
close

Next Article in News

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.